| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Operating Officer | SVP Chief Commercial Officer
2 companies
Van Oene Mark is a See Remarks at PACB, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 42 sales. Those positions are worth an estimated $8.2M at current prices.
Our model assigns Van Oene Mark a strong insider score of 79/100, based on 12 past trades. Over a 12-month horizon, 90.9% of those trades were profitable, with an average 12-month return of +37.8%.
Van Oene Mark's largest disclosed position is in ILMN as SVP Chief Commercial Officer, worth about $5.2M. The recent filings there lean toward selling, a net 15,426 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 26,911 | $1.13 | $30,409.43 | -1.0% | - | - | |
| Mar 3, 2026 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 6,504 | $1.51 | $9,847.06 | -0.3% | +3.6% | - | |
| Feb 18, 2026 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 184,897 | $1.59 | $294,318.34 | -9.6% | -29.4% | - | |
| Aug 18, 2025 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 26,836 | $1.31 | $35,182.00 | -1.4% | +18.0% | -14.3% | |
| Mar 3, 2025 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 6,486 | $1.41 | $9,125.80 | -0.4% | -24.9% | +16.0% | |
| Feb 18, 2025 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 100,773 | $1.88 | $189,251.69 | -6.3% | -45.5% | -12.8% | |
| Jan 10, 2025 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 34,405 | $2.03 | $69,979.77 | -2.1% | -34.3% | -7.6% | |
| Aug 16, 2024 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 38,011 | $1.66 | $63,174.28 | -2.3% | +18.9% | -16.0% | |
| Mar 4, 2024 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 9,186 | $4.87 | $44,745.01 | -0.5% | -61.7% | -72.3% | |
| Feb 16, 2024 | PACB Pacific Biosciences Of California, Inc. | See Remarks | Sell | 33,560 | $5.96 | $199,950.48 | -3.7% | -61.8% | -67.8% |